Jaiturong Patthanakorn, Sirithunyalug Busaban, Eitsayeam Sukum, Asawahame Chawalinee, Tipduangta Pratchaya, Sirithunyalug Jakkapan
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
Department of Physics and Materials, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
Asian J Pharm Sci. 2018 May;13(3):239-247. doi: 10.1016/j.ajps.2017.08.008. Epub 2017 Aug 31.
Glutinous rice starch (GRS) is commonly produced in the Northeast of Thailand. GRS is a biopolymer which is widely used in the food industry but not yet commonly applied within the pharmaceutical industry as an alternative resource. GRS exhibits a branch chain structure which is not feasible to fabricate as nanofiber. Therefore, combining GRS with polyvinyl alcohol (PVA) in hybrid form can be a potential platform to produce GRS-PVA nanofibers. Smooth nanofibers of 2% (w/v) GRS combined with 8% (w/v) PVA were fabricated by an electrospinning process. A scanning electron microscope (SEM) revealed an average diameter size of the GRS-PVA nanofibers equal to 191 ± 25 nm. A highly water soluble model drug, Chlorpheniramine maleate (CPM), was incorporated into the GRS-PVA electrospun fibers to prove a drug delivery carrier concept and drug release control of the nanofibers. The GRS-PVA nanofibers exhibited a biphasic CPM release in which approximately 60% of the drug immediately released in 10 min, and it reached 90% drug release in 120 min. This study demonstrated a potential application of GRS combining with PVA as an oral drug delivery carrier. Therefore, it can be a promised step that expands the application GRS in pharmaceuticals and related areas.
糯米淀粉(GRS)通常产于泰国东北部。GRS是一种生物聚合物,在食品工业中广泛使用,但在制药工业中尚未作为替代资源普遍应用。GRS呈现出一种支链结构,这种结构无法制成纳米纤维。因此,将GRS与聚乙烯醇(PVA)以混合形式结合可以成为生产GRS-PVA纳米纤维的潜在平台。通过静电纺丝工艺制备了2%(w/v)GRS与8%(w/v)PVA混合的光滑纳米纤维。扫描电子显微镜(SEM)显示GRS-PVA纳米纤维的平均直径大小为191±25纳米。一种高度水溶性的模型药物马来酸氯苯那敏(CPM)被掺入GRS-PVA静电纺丝纤维中,以证明纳米纤维的药物递送载体概念和药物释放控制。GRS-PVA纳米纤维呈现出双相CPM释放,其中约60%的药物在10分钟内立即释放,120分钟内药物释放达到90%。本研究证明了GRS与PVA结合作为口服药物递送载体的潜在应用。因此,这可能是在制药及相关领域扩大GRS应用的一个有前景的举措。